RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nasal spray vaccine aims to protect kids from RSV
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new nasal spray vaccine (BLB-201) for RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to see if the vaccine is safe and…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:50 UTC
-
Could a common antibiotic shorten RSV hospital stays in kids?
Disease control Recruiting nowThis study tests whether the antibiotic azithromycin can help children with severe RSV infection who need breathing support in the ICU. Researchers want to see if it shortens hospital stays and reduces time on oxygen. About 370 children will take part, receiving either azithromyc…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 13, 2026 15:59 UTC